期刊文献+

转录因子E2F3对浸润性膀胱癌细胞因子的调控反应 被引量:3

Transcription factors E2F3 regulates cytokine response in invasive bladder cancer
原文传递
导出
摘要 目的 E2F3在浸润性膀胱癌的发生、发展中起着重要作用,但是其具体调控分子机制尚不明确,本研究旨在探讨E2F3对浸润性膀胱癌细胞调控的分子机制。方法采用RNAi技术使E2F3在浸润性膀胱癌细胞系中低表达,通过蛋白质印迹法、PCR进行检测及后续实验,通过CHIP实验等观察E2F3在HT1376和TCCSUP细胞系中与信号转导及转录激活因子3(STAT3)和Ets1之间及其相关侵袭细胞因子的调节关系。结果 E2F3、STAT3和Ets1基因在高表达E2F3细胞系(HT1376和TCCSUP)中成功被沉默,CHIP测序显示,E2F3与Ets1和STAT3基因启动子结合增多只出现在过表达膀胱癌细胞系中;免疫组化和蛋白质印迹法检测结果显示,E2F3过表达细胞癌中,Ets1和STAT3基因过表达,二者呈正相关,r=0.421,P=0.023;E2F3高表达同时相关细胞因子也增加(IL-1、IL-8、TNF-α和VEGFA等),Ets1和STAT3被沉默后,上述细胞因子也相对降低,CHIP实验显示,与低表达E2F3膀胱癌相比,在高表达E2F3膀胱癌中,Ets1和STAT3启动子活性增强。结论 E2F3过表达在人膀胱癌细胞系中通过Ets1和STAT3调节免疫相关基因的表达,E2F3的过表达促进Ets1和STAT3的表达。 OBJECTIVE E2F3 plays an important role in bladder cancer, but the mechanisms of the regulation is not clear. This article is to investigate the mechanisms of E2F3 in invasive bladder cancer. METHODS E2F3 was knock- down in invasive bladder cancer ceils lines by RNAi. By the western, PCR and CHIP experiments to observe the regulation between the E2F3 and STAT3, Etsl as well as invasion related factors. RESULTS E2F3, STAT3 and Etsl were knockdown in E2F3 high-expressing cell lines (HT1376 and TCCSUP), ChIP assays confirmed increased binding of E2F3 to the Etsl and STAT3 promoters in E2F3-overexpressing cell lines related to normal E2F3-expressing cell lines. Immunohistochemistry and Western.. Etsl and STAT3 proeins were increased in high E2F3 bladder cancer, r= 0. 421, P= 0. 023. The cytokines (IL-I,IL-8,TNF-α,VEGFA etc. ) express were increased in overexpression of E2F3 cells, knockdown of Etsl and STAT3 in these cells led to a marked decrease in the expression of most cytokines. CONCLUSIONS E2F3 overexpression in human bladder cancer cell lines modulates the expression of immune related genes through Etsl and STAT3.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2016年第12期768-774,793,共8页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(31272391) 陕西省科学技术研究发展计划(2008k09-04)
关键词 膀胱癌 E2F3 转录激活因子3 RNAI 免疫组织化学 bladder cancer E2F3 signal transducers and activatos of transcription-3 RNAi immunohistochemistry
  • 相关文献

参考文献15

  • 1Sari A, Calli A. Gorgel SN? et al. Immunohistochemical deter-mination of ETS-1 oncoprotein expression in urothelial carcino-mas of the urinary bladder [J ]. Appl Immunohistochem MolMorphol,2012,20(2): 153-158.
  • 2Zhang B,Lu Z, Hou Y, et al. The effects of STAT3 and Sur-vivin silencing on the growth of human bladder carcinoma cells[J]. Tumour IiioK 2014 ,35(6) : 5401-5407.
  • 3Kim J, Akbani R,Creighton CJ. et al. Invasive bladder cancer:genomic insights and therapeutic promise[J]. Clin Cancer Res,2015,21(20): 4514-4524.
  • 4Fujimoto J, Aoki I,Toyoki H, et al. Clinical implications of ex-pression of ETS-1 related lo angiogenesis in metastatic lesions ofovarian cancers[J], Oncology ,2004 ,66(5) : 420-428.
  • 5Keehn CA, Smoller I^R. Morgan MB. Expression of the ets-1protooncogene in melanocytic lesions[J]. Mod Pathol, 2003,16(23):772-777.
  • 6杨庞,杨罗艳,熊剑华,黄小彬.Ets-1、MMP-1及TIMP-1在膀胱移行细胞癌中的表达[J].医学临床研究,2006,23(11):1703-1706. 被引量:2
  • 7Keehn CA, Smoller BR, Morgan MB. Ets-1 immunohistochemi-cal expression in non-melanoma skin carcinoma [J]. J CutanPathol, 2004,31(2):8-13.
  • 8吴朝,董自强.STAT3及其抑制剂在膀胱癌中的研究进展[J].东南大学学报(医学版),2015,34(2):313-316. 被引量:6
  • 9Ho PL, Lay EJ, Jian W, et al. Stat3 activation in urothelialstem cells leads to direct progression to invasive bladder cancer[J]. Cancer Res, 2012 ,72(13) : 3135-3142.
  • 10张建龙,张育超,孙健,何传超,褚忠华.肝再生磷酸酶-3-信号传导和转录激活子3-微小RNA21信号通路促进结肠癌细胞增殖侵袭的研究[J].中华实验外科杂志,2012,29(10):2003-2005. 被引量:4

二级参考文献42

  • 1陈扬华,黄金宁,周雄,张子恒,梁丽棠.上皮钙黏附素和树突细胞在膀胱癌中的表达及其意义[J].中华实验外科杂志,2006,23(7):858-859. 被引量:10
  • 2Tuault S, Tan E J, Peinado H, et al. HMGA2 and smads co-regulate SNA1L1 expression during induction of epithelial-mesenchylnal, transition. J Biol Chem,2008 ,283 :33437-33446.
  • 3Boyer B, Valles AM, Edme N. Induction and regulation of epithelialmesenchymal transitions. Biochem Pharmacol,2000,60 : 1091-1099.
  • 4Agnes Mialhe, Geraldine Levacher, Pierre Champelovier, et al. Expression of E-,P-, N-cadherin and Catenins in human bladder carcinoma cell lines. J Uro1,2000,164:826-835.
  • 5Gohji K,Okamoto M,Kitazawa S,et al.Heparanase protein and gene expression in bladder cancer[J].J Urol,2001,166:1286-1290.
  • 6Kroft SH,Oyasu R.Urinary bladder cancer:mechanisms of development and progression[J].Lab Invest,1994,71:158-174.
  • 7John P,Stein GD,Miles A,et al.Prognostic markers in bladder cancer.A contemporary review of the literature[J].J Urol,1998,160:645-659.
  • 8Watanabe D,Takagi H,Suzuma K,et al.Transcription factor Ets-1 mediates ischemia and VEGF-dependent retinal neovascularization[J].Invest Ophthalmol Vis Sci,2003,44:E-Abstract,2268.
  • 9Rutter JL,Mitchell TI,Buttice G,et al.A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription[J].Cancer Res,1998,58(23):5321-5325.
  • 10Kitnage G,Shibata S,Tokunaga Y,et al.Ets-1 transcription factor-mediated urokinase-type plasinogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factor[J].Lab Invest,1999,79(4):407-416.

共引文献11

同被引文献10

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部